K Ray Chaudhuri Selected Research

Apomorphine

1/2022	Apomorphine infusion for improving sleep in Parkinson's disease.
10/2021	Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry.
7/2021	Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors.
1/2021	Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured Review.
1/2021	Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study.
1/2020	Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson's disease management in developing countries.
1/2018	Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.
12/2016	The efficacy of apomorphine - A non-motor perspective.
12/2016	Apomorphine therapy in Parkinson's and future directions.
12/2016	Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Ray Chaudhuri Research Topics

Disease

94	Parkinson Disease (Parkinson's Disease) 03/2022 - 01/2002
23	Dyskinesias (Dyskinesia) 01/2022 - 10/2002
13	Pain (Aches) 03/2022 - 10/2004
7	Restless Legs Syndrome (Restless Legs) 01/2021 - 10/2002
5	Dementia (Dementias) 11/2020 - 11/2002
5	Parkinsonian Disorders (Parkinsonism) 01/2017 - 11/2002
5	Multiple System Atrophy 01/2016 - 06/2002
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2017
4	Movement Disorders (Movement Disorder) 01/2022 - 10/2002
4	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2021 - 11/2002
4	Tremor (Tremors) 11/2020 - 11/2002
3	Sleepiness 03/2022 - 01/2002
3	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2022 - 12/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2017
3	Cognitive Dysfunction 01/2021 - 04/2017
3	Disorders of Excessive Somnolence (Hypersomnia) 01/2018 - 01/2002
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2016 - 01/2016
2	Chronic Pain 04/2022 - 01/2016
2	Constipation 03/2022 - 01/2021
2	Infections 01/2022 - 12/2017
2	COVID-19 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2020 - 01/2012
2	Hallucinations (Hallucination) 04/2017 - 10/2004
1	Orthostatic Hypotension (Postural Hypotension) 03/2022
1	Inflammation (Inflammations) 03/2022
1	Dysbiosis 03/2022
1	Iron Deficiencies 11/2021
1	Back Pain (Backache) 02/2021
1	Bulimia (Binge Eating) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Death (Near-Death Experience) 01/2021
1	Feeding and Eating Disorders (Eating Disorder) 01/2021
1	Synucleinopathies 01/2021
1	Sleep Deprivation 01/2021
1	Sialorrhea 12/2020
1	Fatigue 11/2020
1	Phobic Disorders (Phobia) 01/2020
1	Polyneuropathies (Polyneuropathy) 12/2017
1	Illusions (Auditory Illusions) 04/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Abnormal Reflex (Hyperreflexia) 01/2017
1	Sensation Disorders 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 12/2016
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 12/2016

Drug/Important Bio-Agent (IBA)

42	Levodopa (L Dopa)FDA LinkGeneric 03/2022 - 01/2002
15	Dopamine Agonists (Dopamine Agonist)IBA 01/2022 - 01/2002
14	Apomorphine FDA Link 01/2022 - 12/2009
14	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
13	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2012
13	Carbidopa (Lodosyn)FDA LinkGeneric 01/2022 - 07/2009
10	rotigotine FDA Link 01/2022 - 03/2007
8	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 01/2002
4	Analgesics (Analgesic Drugs)IBA 04/2022 - 12/2015
3	opicaponeIBA 03/2022 - 01/2020
3	propylene diquat (PDQ(+))IBA 01/2022 - 09/2012
2	SynucleinsIBA 03/2022 - 01/2016
2	SuspensionsIBA 12/2021 - 01/2021
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 10/2021 - 01/2021
2	Cholinergic Agents (Cholinergics)IBA 07/2021 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 04/2017 - 12/2016
2	Pramipexole (Mirapex)FDA LinkGeneric 12/2009 - 01/2002
2	ropinirole (Requip)FDA LinkGeneric 12/2009 - 01/2002
2	Cabergoline FDA LinkGeneric 05/2005 - 10/2002
1	DroxidopaIBA 03/2022
1	Dopa DecarboxylaseIBA 03/2022
1	benzoyl L-arginine methyl ester (BAME)IBA 01/2022
1	ProgranulinsIBA 12/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	EndocannabinoidsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Amantadine (Aman)FDA LinkGeneric 12/2019
1	Apolipoproteins E (ApoE)IBA 04/2017
1	pimavanserinIBA 02/2017
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017
1	alpha-SynucleinIBA 01/2017
1	Pain-FreeIBA 01/2017
1	naxagolideIBA 12/2016
1	Dopamine D3 ReceptorsIBA 12/2016
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2016

Therapy/Procedure

32	Therapeutics 03/2022 - 01/2002
10	Palliative Care (Palliative Therapy) 01/2022 - 01/2012
10	Deep Brain Stimulation 10/2021 - 11/2013
5	Transdermal Patch 01/2022 - 10/2015
4	Precision Medicine 12/2019 - 01/2017
2	Activities of Daily Living (ADL) 01/2022 - 01/2021
2	Subcutaneous Infusions 07/2021 - 01/2018
1	Analgesia 04/2022
1	Fecal Microbiota Transplantation 03/2022
1	Ambulatory Care (Outpatient Care) 01/2022
1	Denervation 01/2021
1	Wearable Electronic Devices 01/2018
1	Cognitive Training 04/2017
1	Complementary Therapies (Alternative Medicine) 01/2017